Double-Blind Randomized Controlled Clinical Trial of the Interleukin-6 Receptor Antagonist, Tocilizumab, in European Patients With Rheumatoid Arthritis Who Had an Incomplete Response to Methotrexate

2007 ◽  
Vol 2007 ◽  
pp. 8-10
Author(s):  
D.L. Kimpel
Sign in / Sign up

Export Citation Format

Share Document